Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should Canada allow direct-to-consumer advertising of prescription drugs?: no.

× No keyword cloud information.

10 in total

1. Direct-to-consumer prescription drug advertising in Canada: permission by default?

Authors: David M Gardner; Barbara Mintzes; Aleck Ostry
Journal: CMAJ Date: 2003-09-02 Impact factor: 8.262

Review 2. Benefits and harms of direct to consumer advertising: a systematic review.

Authors: S Gilbody; P Wilson; I Watt
Journal: Qual Saf Health Care Date: 2005-08

3. Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising.

Authors: Dominick L Frosch; Patrick M Krueger; Robert C Hornik; Peter F Cronholm; Frances K Barg
Journal: Ann Fam Med Date: 2007 Jan-Feb Impact factor: 5.166

4. A decade of direct-to-consumer advertising of prescription drugs.

Authors: Julie M Donohue; Marisa Cevasco; Meredith B Rosenthal
Journal: N Engl J Med Date: 2007-08-16 Impact factor: 91.245

5. Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing.

Authors: Michele M Spence; Stephanie S Teleki; T Craig Cheetham; Stuart O Schweitzer; Mirta Millares
Journal: Med Care Res Rev Date: 2005-10 Impact factor: 3.929

6. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.

Authors: Richard L Kravitz; Ronald M Epstein; Mitchell D Feldman; Carol E Franz; Rahman Azari; Michael S Wilkes; Ladson Hinton; Peter Franks
Journal: JAMA Date: 2005-04-27 Impact factor: 56.272

7. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.

Authors: David J Graham; David Campen; Rita Hui; Michele Spence; Craig Cheetham; Gerald Levy; Stanford Shoor; Wayne A Ray
Journal: Lancet Date: 2005 Feb 5-11 Impact factor: 79.321

8. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.

Authors: Barbara Mintzes; Morris L Barer; Richard L Kravitz; Ken Bassett; Joel Lexchin; Arminée Kazanjian; Robert G Evans; Richard Pan; Stephen A Marion
Journal: CMAJ Date: 2003-09-02 Impact factor: 8.262

9. The impact of antidepressant treatment on population health: synthesis of data from two national data sources in Canada.

Authors: Scott B Patten
Journal: Popul Health Metr Date: 2004-11-01

10. Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study.

Authors: Michael R Law; Sumit R Majumdar; Stephen B Soumerai
Journal: BMJ Date: 2008-09-02

10 in total

5 in total

1. Health care's ills: A Catholic diagnosis.

Authors: Angus Sibley
Journal: Linacre Q Date: 2016-11

2. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Authors: Tim K Mackey
Journal: Int J Health Policy Manag Date: 2016-02-03

Review 3. Strategies to promote public engagement around deprescribing.

Authors: Justin P Turner; Janet Currie; Johanna Trimble; Cara Tannenbaum
Journal: Ther Adv Drug Saf Date: 2018-09-12

4. Feeling Is Believing: Evaluative Conditioning and the Ethics of Pharmaceutical Advertising.

Authors: Paul Biegler; Patrick Vargas
Journal: J Bioeth Inq Date: 2016-01-27 Impact factor: 1.352

5. Sources of drug information and their influence on the prescribing behaviour of doctors in a teaching hospital in Ibadan, Nigeria.

Authors: Kazeem Adeola Oshikoya; Ibrahim Oreagba; Olayinka Adeyemi
Journal: Pan Afr Med J Date: 2011-06-03

5 in total